|
Sign In to gain access to subscriptions and/or personal tools.
|
Blockade of the renin-angiotensin-aldosterone system and renal protection in diabetes mellitus
Hans-Henrik Parving
Steno Diabetes Center Niels Steensens Vej 2 DK-2820 Gentofte Denmark, hhparving{at}dadlnet.dk
Key Words: hypertension diabetes renin-angiotensin-aldosterone system renal protection ACE inhibitors
References
- Parving H-H., sterby R., Anderson PW, Hsueh WA Diabetic nephropathy. In: Brenner BM, editor. The Kidney. 5th ed. Philadelphia: Saunders, 1996:1864-1892.
- Parving H-H. Renoprotection in diabetes: genetic and non-genetic risk factors and treatment. Diabetologia 1998; 41:745-759.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Hostetter TH, Rennke HG, Brenner BM The case for intrarenal hypertension in the initiation and progression of diabetic and other glomerulopathies. Am J Med 1982; 72:375-380.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Zatz R., Dunn BR, Meyer TW, Anderson S., Rennke HG, Brenner BM Prevention of diabetic glomerulopathy by pharmacological amelioration of glomerular capillary hypertension. J Clin Invest 1986; 77:1925-1930.[Web of Science][Medline]
[Order article via Infotrieve]
- Deinum J., Tarnow L., van Gool JM, et al. Plasma renin and prorenin and renin gene variation in patients with insulin-dependent diabetes mellitus and nephropathy. Nephrol Dial Transplant 1999; 14:1904-1911.1.[Abstract/Free Full Text]
- De'Oliveira JM, Price DA, Fisher NDL, et al. Autonomy of the renin system in type II diabetes mellitus: dietary sodium and renal hemodynamic responses to ACE inhibition. Kidney Int 1997; 52:771-777.[Web of Science][Medline]
[Order article via Infotrieve]
- Wagner J., Gehlen F., Ciechanowicz A., Ritz E. Angiotensin II receptor type 1 gene expression in human glomerulonephritis and diabetes mellitus. J Am Soc Nephrol 1999; 10:545-551.[Abstract/Free Full Text]
- Tarnow L., Gluud C., Parving H-H. Diabetic nephropathy and the insertion/deletion polymorphism of the angiotensin-converting enzyme gene. Nephrol Dial Transplant 1998; 13:1125-1130.[Free Full Text]
- Parving H-H., Jacobsen P., Tarnow L. et al. Effect of deletion polymorphism of angiotensin-converting enzyme gene on progression of diabetic nephropathy during inhibition of angiotensin-converting enzyme: observational follow up study. Br Med J 1996; 313:591-594.[Abstract/Free Full Text]
- The Euclid Study Group. Randomised placebo-controlled trial of lisinopril in normotensive patients with insulin-dependent diabetes and normoalbuminuria or microalbuminuria. Lancet 1997; 349:1787-1792.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Ravid M., Brosh D., Levi Z., Bar-Dayan Y., Ravid D., Rachmani R. Use of enalapril to attennuate decline in renal function in normotensive, normoalbuminuric patients with type 2 diabetes mellitus. Ann Intern Med 1998; 128:982-988.[Abstract/Free Full Text]
- Marre M., Leblanc H., Suarez L., Guyenne T-T., Ménard J., Passa P. Converting enzyme inhibition and kidney function in normotensive diabetic patients with persistent microalbuminuria. Br Med J 1987; 294:1448-1452.[Abstract/Free Full Text]
- Mogensen CE, Keane WF, Bennett PH et al. Prevention of diabetic renal disease with special reference to microalbuminuria. Lancet 1995; 346:1080-1084.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Mathiesen ER, Hommel E., Hansen HP, Smidt UM, Parving H-H. Randomised controlled trial of long term efficacy of captopril on preservation of kidney function in normotensive patients with insulin dependent diabetes and microalbuminuria. Br Med J 1999; 319:24-25.[Free Full Text]
- Ravid M., Savin H., Jutrin I., Bental T., Katz B., Lishner M. Long-term stabilizing effect of angiotensin-converting enzyme inhibition on plasma creatinine and on proteinuria in normotensive type II diabetic patients. Ann Intern Med 1993; 118:577-581. 16. Hommel E., Parving H-H., Mathiesen ER, Edsberg B., Nielsen MD, Giese J. Effect of captopril on kidney function in insulin-dependent diabetic patients with nephropathy. Br Med J 1986; 293:466-470.
- Björck S., Nyberg G., Mulec H., Granerus G., Herlitz H., Aurell M. Beneficial effect of angiotensin-converting enzyme inhibition on renal function in patients with diabetic nephropathy. Br Med J 1986; 293:471-474.[Web of Science][Medline]
[Order article via Infotrieve]
- Björck S., Mulec H., Johnsen SA, Nordén G., Aurell M. Renal protective effect of enalapril in diabetic nephropathy. Br Med J 1992; 304:339-343.[Web of Science][Medline]
[Order article via Infotrieve]
- Lewis E., Hunsicker L., Bain R., Rhode R. The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. N Engl J Med 1993; 329:1456-1462. 20. Andersen S., Tarnow L., Rossing P., Hansen BV, Parving H-H. Renoprotective effects of angiotensin II receptor blokade in type 1 diabetic patients with diabetic nephropathy. Kidney Int 2000; In press.
Journal of Renin-Angiotensin-Aldosterone System, Vol. 1, No. 1,
30-31 (2000)
DOI: 10.3317/jraas.2000.006

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati Twitter What's this?
|
|